KARDIOMICS PTY LTD is an Australian Private Company registered in New South Wales. The ABN was registered on the 28 November 2022 and is currently registered for GST and has been since the 1 July 2024. It was registered with ASIC on the 28 November 2022 as an Australian proprietary company, Limited by Shares.
Kardiomics Pty Ltd is an Australian biotechnology spin-out company founded through the University of Sydney and the Royal North Shore Hospital. The company specialises in the early detection of coronary artery disease by targeting cardiovascular inflammation. It has developed a blood-based diagnostic product called Redoxmer, which utilises aptamer technology to test for early-stage coronary artery inflammation within standard pathology laboratory operations.
We weren't able to find any other public information on this company.
| Entity ID | Name | Status |
|---|
WGEA workforce data loads when this section is in view.